These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8232506)

  • 1. Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
    Andersen JW; Smalley RV
    N Engl J Med; 1993 Dec; 329(24):1821-2. PubMed ID: 8232506
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Salloum E; Levin M
    N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764
    [No Abstract]   [Full Text] [Related]  

  • 5. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):32-5. PubMed ID: 8073307
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Kosmas C; Malamos NA; Antonopoulos MJ
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Decaudin D
    N Engl J Med; 1998 Nov; 339(20):1477. PubMed ID: 9841321
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
    Michiels JJ
    Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
    [No Abstract]   [Full Text] [Related]  

  • 9. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 11. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy for localized non-Hodgkin's lymphoma.
    Cosset JM
    N Engl J Med; 1998 Jul; 339(1):44-5. PubMed ID: 9647881
    [No Abstract]   [Full Text] [Related]  

  • 16. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Mounier N; Gisselbrecht C; Lepage E
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
    Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
    Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
    [No Abstract]   [Full Text] [Related]  

  • 19. Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.
    Meyer RM; Quirt IC; Skillings JR; Cripps MC; Bramwell VH; Weinerman BH; Gospodarowicz MK; Burns BF; Sargeant AM; Shepherd LE
    N Engl J Med; 1993 Dec; 329(24):1770-6. PubMed ID: 7694148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.